CDC20 and acute leukemia: Compound 9, which is characterized by 2-aminopyrimidyl- and trichloroethyl- moieties, similarly to those found in Apcin [128], a small molecule that blocks the interaction between the anaphase-promoting complex/cyclosome (APC/C) and CDC20 [53], showed a selective activity against acute leukemia models over solid tumors.